The Cigna Group (CI)
- Previous Close
350.97 - Open
351.60 - Bid 351.15 x 800
- Ask 351.90 x 800
- Day's Range
350.07 - 352.02 - 52 Week Range
240.50 - 365.71 - Volume
54,479 - Avg. Volume
1,483,166 - Market Cap (intraday)
99.592B - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
28.78 - EPS (TTM)
12.18 - Earnings Date Aug 1, 2024
- Forward Dividend & Yield 5.60 (1.60%)
- Ex-Dividend Date Jun 4, 2024
- 1y Target Est
391.24
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
www.cigna.comRecent News: CI
Performance Overview: CI
Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CI
Valuation Measures
Market Cap
99.70B
Enterprise Value
124.03B
Trailing P/E
28.82
Forward P/E
12.38
PEG Ratio (5yr expected)
0.89
Price/Sales (ttm)
0.51
Price/Book (mrq)
2.42
Enterprise Value/Revenue
0.61
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.77%
Return on Assets (ttm)
3.08%
Return on Equity (ttm)
8.97%
Revenue (ttm)
204.15B
Net Income Avi to Common (ttm)
3.62B
Diluted EPS (ttm)
12.18
Balance Sheet and Cash Flow
Total Cash (mrq)
9.35B
Total Debt/Equity (mrq)
79.25%
Levered Free Cash Flow (ttm)
3.84B
Research Analysis: CI
Company Insights: CI
CI does not have Company Insights
Research Reports: CI
Cigna Earnings: Boosts 2024 Outlook Mildly as Its Unique Business Mix Shines
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.
RatingPrice TargetRating increased to a BUY
THE CIGNA GROUP has an Investment Rating of BUY; a target price of $375.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $370.00
THE CIGNA GROUP has an Investment Rating of HOLD; a target price of $370.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $364.00
THE CIGNA GROUP has an Investment Rating of HOLD; a target price of $364.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target